A. Goracci, M. Martinucci, A. Mazza, G. Filippone, P. Castrogiovanni - Vol. 10, December 2004, Issue 4
Testo Bibliografia Summary Indice
Aspetti transnosografici delle dimensioni psicopatologiche
della mania. 1 - L’impulsività
Transnosography of impulsiveness, one of the psychopathological dimensions
of mania
1 Cassano GB. Manuale di Psichiatria. Torino: UTET 1997.
2 Giannini A, Castrogiovanni P. L’euforia morbosa. Milano: Franco Angeli 1977.
3 Nardini M, Clemente P, Di Sciascio G, Bertolino A, Bellomo A, Labriola D. Correlati neurobiologici dell’aggressività ed implicazioni di trattamento farmacologico: una review. In: Personality Disorders and Aggressiveness: Diagnostic and Therapeutic Approaches. Perugia: ARP 2000.
4 American Psychiatric Association. DSM-IV-TR. Manuale diagnostico e statistico dei disturbi mentali, quarta edizione, text revision. Milano: Masson 2001.
5 Pini S, Marazziti D, Calzeroni A, Zanardi R, Sacchetti E, Gasperini M, et al. Disturbi dell’Umore. In: Cassano GB, Pancheri P, eds. Trattato italiano di psichiatria. Milano: Masson 1999, pp. 1837-2007.
6 Tundo A, Cassano GB. Disturbi dell’Umore. In: Cassano GB, ed. Manuale di Psichiatria. Torino: UTET 1994, pp. 239-306.
7 Devoto G, Oli GC. Il dizionario della lingua italiana. Firenze: Le Monnier 1995.
8 Freud S. Tre saggi sulla teoria sessuale (1905). Opere di Sigmund Freud. Torino: Boringhieri 1989 (tr. it.).
9 Esquirol E. Des Maladies mentales. Bruxelles: Meline Cans et C. 1838.
10 Tanzi E. Trattato delle malattie mentali. Milano: Società Editrice Libraria 1905.
11 Muller C. Lessico di psichiatria. Padova: Piccin 1980 (tr. it.).
12 Murray H. Explorations in Personality. New York: Oxford University Press 1938.
13 Bannister D, Fransella F. L’uomo ricercatore. Torino: Bollati Boringhieri 1972.
14 Barratt ES, Stanford MS, Kent TA, Felthous A. Neuropsychological and cognitive psychophysiological substrates of impulsive aggression. Biol Psychiatry 1997;41:1045-61.
15 Koukopoulos A, Faedda G, Proietti R, D’Amico, S, de Pisa E, Simonetto C. Mixed depressive syndrome. Encephale 1992;18(Spec 1):19-21.
16 Suominen K, Isometsa E, Henriksson M, Ostamo A, Lonqvist J. Hopelessness, impulsiveness and intent among suicide attempters with major depression, alcohol dependence, or both. Acta Psychiatr Scand 1997;96:142-9.
17 Rutz W, Walinder J, Rhimer Z, Pestality P. Male depression - stress reaction combined with serotonin deficiency? Lakartidningen 1999;96:1177-8.
18 Swann AC, Anderson JC, Dougherty DM, Moeller FG. Measurement of inter-episode impulsivity in bipolar disorder. Psychiatry Res 2001;101:195-7.
19 Hantouche EG, Lancrenon S, Bouhassira M, Ravily V, Bourgeois ML. Repeat evaluation of impulsiveness in a cohort of 155 patients with obsessive-compulsive disorder: 12 months prospective follow-up. Encephale 1997;23:83-90.
20 Ketzenberger KE, Forrest L. Compulsiveness and impulsiveness: unidimensional or bidimensional constructs? Psychol Rep 1998;83:303-6.
21 Joseph R. Frontal lobe psychopathology: mania, depression, confabulation, catatonia, perseveration, obsessive compulsions and schizophrenia. Psychiatry 1999;62:138-72.
22 Wingerson D, Sullivan M, Dager S, Flick S, Dunner D, Roy-Byrne P. Personality traits and early discontinuation from clinical trials in anxious patients. J Clin Psychopharmacol 1993;13:194-7.
23 Spivak B, Mester R, Wittenberg N, Maman Z, Weizman A. Reduction of aggressiveness and impulsiveness during clozapine treatment in chronic neuroleptic-resistant schizophrenic patients. Clin Neuropharmacol 1997;20:442-6.
24 Pancheri P, Macciardi F, Carreda M, Carilli L, Delle Chiaie R, Kotzalidis G, et al. Schizofrenia. In: Cassano GB, Pancheri P, eds. Trattato italiano di psichiatria. Milano: Masson 1999, pp. 1509-781.
25 Fahy T, Eisler I. Impulsivity and eating disorders. Br J Psychiatry 1993;162:193-7.
26 Brewerton TD, Hand LD, Bishop ER Jr. The tridimensional Personality Questionnaire in eating disorder patients. Int J Eat Disord 1993;14:213-8.
27 Kent A, Goddard KL, Van den Berk PA, Raphael FJ, McCluskey SE, Lacey JH. Eating disorder in women admitted to hospital following deliberate self-poisoning. Acta Psychiatr Scand 1997;95:140-4.
28 Monteleone P, Brambilla F, Bortolotti F, Ferraro C, Maj M. Plasma prolactin response to D-fenfluramine is blunted in bulimic patients with frequent binge episodes. Psychol Med 1998;28:975-83.
29 Nevonen L, Broberg AG. Validating the eating disorder inventory-2 (EDI-2) in Sweden. Eat Weight Disord 2001;6:59-67.
30 Camatta CD, Nagoshi CT. Stress, depression, irrational beliefs, and alcohol use and problems in a college student sample. Alcohol Clin Exp Res 1995;19:142-6.
31 Kravitz HM, Fawcett J, McGuire M, Kravitz GS, Whitney M. Treatment attrition among alcohol-dependent men: is it related to novelty seeking personality traits? J Clin Psychopharmacol 1999;19:51-6.
32 Ketzenberger KE, Forrest L. Impulsiveness and compulsiveness in alcoholics and nonalcoholics. Addict Behav 2000;25:791-5.
33 Soloff PH, Lynch KG, Moss HB. Serotonin, impulsivity, and alcohol use disorders in the older adolescent: a psychobiological study. Alcohol Clin Exp Res 2000;24:1609-19.
34 Petry M. Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls. Psychopharmacology 2001;154:243-50.
35 Vukov M, Baba-Milkic N, Lecic D, Mijalkovic S, Marinkovic J. Personality dimensions of opiate addicts. Acta Psychiatr Scand 1995;91:103-7.
36 Kirby KN, Petry NM, Bickel WK. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen 1999;128:78-87.
37 Morgan MJ. Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 1998;19:252-64.
38 Sommese T, Patterson JC. Acute effects of cigarette smoking withdrawal: a review of the literature. Aviat Space Environ Med 1995;66:164-7.
39 Russo J, Katon W, Sullivan M, Clark M, Buchwald D. Severity of somatization and its relationship to psychiatric disorders and personality. Psychosomatics 1994;35:546-56.
40 Lindback T, Strand G. Tourette syndrome in children. An analysis of everyday problems-neurology or emotional conflicts? Tidsskr Nor Laegeforen 1994;114:2248-51.
41 Scahill L, Ort SI, Hardin MT. Tourette’s syndrome, Part I: Definition and diagnosis. Arch Psychiatr Nurs 1993;7:203-8.
42 Scahill L, Lynch KA, Ort SI. Tourette syndrome: update and review. J Sch Nurs 1995;11:26-32.
43 Bellak L, Black RB. Attention-deficit hyperactivity disorder in adults. Clin ther 1992;14:138-47.
44 King Ja, Barkley RA, Barret S. Attention-deficit hyperactivity disorder and the stress response. Biol Psychiatry 1998;44:72-4.
45 Sonuga-Barke EJ, Houlberg K, Hall M. When is "impulsiveness" not impulsive? The case of hyperactive children’s cognitive style. J Child Psychol Psychiatry 1994;35:1247-53.
46 Brody JF. Evolutionary recasting: ADHD, mania and its variants. J Affect Disord 2001;65:197-215.
47 Merrel C, Tymms PB. Inattention, hyperactivity and impulsiveness: their impact on academic achievement and progress. Br J Educ Psychol 2001;71:43-56.
48 Kafka MP. Successful treatment of paraphilic coercive disorder (a rapist) with fluoxetine hydrochloride. Br J Psychiatry 1991;158:844-7.
49 Lejoyeux M, Feuche N, Loi S, Solomon J, Ades J. Impulse-control disorders in alcoholics are related to sensation seeking and not to impulsivity. Psychiatry Res 1998;81:149-55.
50 Vitaro F, Arseneault L, Tremblay RE. Impulsivity predicts problem gambling in low SES adolescent males. Addiction 1999;94:565-75.
51 Won Kim S, Grant JE. Personality dimensions in pathological gambling disorder and obsessive-compulsive disorder. Psychiatry Res 2001;104:205-12.
52 Stein DJ, Mullen L, Islam MN, Cohen L, De Caria CM, Hollander E. Compulsive and impulsive symptomatology in trichotillomania. Psychopathology 1995;28:208-13.
53 Martens WH. Effects of antisocial or social attitudes on neurobiological functions. Med Hypotheses 2001;56:664-71.
54 Paris J. Social risk factors for borderline personality disorder: a review and hypothesis. Can J Psychiatry 1992;37:510-5.
55 Machizawa S. Borderline personality disorder. Nippon Rinsho 1994;52:1360-4.
56 Links PS, Mitton MJ, Steiner M. Stability of borderline personality disorder. Can J Psychiatry 1993;38:255-9.
57 Wilberg T, Urnes O, Friis S, Pedersen G, Karterud S. Borderline and avoidant personality disorders and the five-factor model of personality: a comparison between DSM-IV diagnoses and NEO-PI-R. J Personal Disord 1999;13:226-40.
58 Diepold B. Borderline developmental disorders in children on theory and treatment. Prax Kinderpsychol Kinderpsychiatr 1995;44:270-9.
59 Verkes RJ, Pijl H, Meinders AE, VanKempen GM. Borderline personality, impulsiveness, and platelet monoamine measures in bulimia nervosa and recurrent suicidal behavior. Biol Psychiatry 1996;40:173-80.
60 Svanborg P, Mattila-Evenden M, Gustavsson PJ, Uvnas-Moberg K, Asberg M. Associations between plasma glucose and DSM-III-R cluster B personality traits in psychiatric outpatients. Neuropsychobiology 2000;41:79-87.
61 Schulte HM, Hall MJ, Crosby R. Violence in patients with narcissistic personality pathology: observations of a clinical series. Am J Psychother 1994;48:610-23.
62 Milner B. Some effects of frontal lobectomy in man. In: Warren JM, Aker K, eds. The frontal granular cortex and behavior. New York: McGraw-Hill 1964.
63 Brown CS, Kent TA, Bryant SG, Gevedon RM, Campbell JL, Felthous AR, et al. Blood platelet uptake of serotonin in episodic aggression. Psychiatry Res 1989;27:5-12.
64 Coccaro EF. Central serotonin and impulsive aggression. Br J Psychiatry 1989;155:52-62.
65 O’Keane V, Maloney E, O’Neill H, O’Connor A, Smith C, Dinan TG. Blunted prolactin responses to D-fenfluramine in sociopathy: evidence for subsensitivity of central serotonergic function. Br J Psychiatry 1992;160:643-6.
66 Coccaro EF, Silverman JM, Klar HM, Horvath TB, Siever LJ. Familial correlates of reduced central serotonergic function in patients with personality disorders. Arch Gen Psychiatry 1994;51:318-24.
67 Soubrie P, Bizot JC. Monoaminergic control of waiting capacity (impulsivity) in animals, in Violence and Suicidality. New York: Van Praag HM, Plutchik R, Apter A, Brunner/Mazel 1990.
68 Brown GL, Linnoila MI. CSF serotonin metabolite (5-HIAA) studies in depression, impulsivity, and violence. J Clin Psychiatry 1990;51:31-43.
69 Depue RA, Spoont MA. Conceptualizing a serotonin trait: a behavioural dimension of constraint. In: Psychobiology of Suicidal Behavior. Ann N Y Acad Sci 1986, pp. 47-62.
70 King R. Motivational diversity and mesolimbic dopamine: a hypothesis concerning temperament. In: Biological Foundations of Emotion. Academic Press 1986, pp. 363-80.
71 Hollander E. Treatment of obsessive-compulsive spectrum disorders with SSRIs. Br J Psychiatry 1998;35(Suppl):7-12.
72 Pierson A, Partiot A, Jouvent R, Bungener C, Martinerie J, Renault B, et al. Loss of control of pre-motor activation in anxious agitated and impulsive depressives. A clinical and ERP study. Prog Neuropsychopharmacol Biol Psychiatry 1994;18:1037-50.
73 Fawcett J, Busch KA, Jacobs D, Kravitz HM, Fogg L. Suicide: a four-pathway clinical-biochemical model. Ann N Y Acad Sci 1997;836:288-301.
74 Virkkunen M, Linnoila M. Brain serotonin, type II alcoholism and impulsive violence. J Stud Alcohol 1993;11(Suppl):163-9.
75 Virkkunen M, Kallio E, Rawlings R, Tokola R, Poland RE, Guidotti A, et al. Personality profiles and state aggressiveness in Finnish alcoholic, violent offenders, fire setters, and healty volunteers. Arch Gen Psychiatry 1994;51:28-33.
76 Verkes RJ, Fekkes D, Zwinderman AH, Hengeveld MW, Van der Mast RC, Tuyl JP, et al. Platelet serotonin and 3H paroxetine binding correlate with recurrence suicidal behavior. Psychopharmacology 1997;132:89-94.
77 Verkes RJ, Pijl H, Meinders AE, Van Kempen GM. Bordeline personality, impulsiveness, and platelet monoamine measure bulimia nervosa and recurrent suicidal behavior. Biol Psychiatry 1996;40:173-80.
78 Koukopoulos A, Pani L, Serra G, Minnai G, Reginaldi D. Anxious-excited depression: a mixed affective syndrome. Encephale 1995;21:33-6.
79 Etain B, Bonnet-Perrin E. Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature. Enchephale 2001;27:280-9.
80 Alarcon RD, Johnson BR, Lucas JP. Paranoid and aggressive behavior in two obsessive-compulsive adolescents treated with clomipramine. J Am Child Adolesc Psychiatry 1991;30:999-1002.
81 Vartiainen H, Tiihonem J, Putkonen A, Koponen H, Virkkunen M, Hakola P, et al. Citalopram, a selective serotonin reuptake inhibitor, in the treatment of aggression in schizophrenia. Acta Psychiatr Scand 1995;91:348-51.
82 Fava M. Psychopharmacologic treatment of pathologic aggression. Psychiatr Clin North Am 1997;20:427-51.
83 Joy CB, Adams CE, Lawrie SM. Haloperidol versus placebo for schizophrenia (Cochrane Review). Cochrane Database Syst Rev 2001;2:CD003082.
84 Briken P, Nika E, Berner W. Treatment of paraphilia with lutinizing hormone-realising hormone agonists. J Sex Marital Ther 2001;27:45-55.
85 Bazire S. Psychotropic Drug Directory. Nr Salisbury, Wilts, Quay Books 1997.
86 Ratey JJ, Greenberg MS, Lindem KJ. Combination of treatments for attention deficit hyperactivity disorder in adults. J Nerv Ment Dis 1991;179:699-701.
87 Tyrer P, Seivewright N. Pharmacological treatment of personality disorders. Clin Neuropharmacol 1988;11:493-9.
88 Mattes JA. Valproic acid nonaffective aggression in the mentally retarded. J Nerv Ment Dis 1992;180:601-2.
89 Rothenhausler HB, Kapfhammer HP. Outcome in borderline disorders. A literature review. Fortschr Neurol Psychiatr 1999;67:200-17.
90 Soler J, Campins MJ, Perez V, Puigdemont D, Perez-Blanco E, Alvarez E. Olanzapine and cognitive-behavioural group therapy in borderline personality disorder. Actas Esp Psiquiatr 2001;29:85-90.
91 Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF. Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry 1993;50:377-85.
92 Kavoussi R, Liu J, Coccaro EF. An open trial of sertraline in personality disordered patients with impulsive aggression. J Clin Psychiatry 1994;55:137-41.
93 Markovitz PJ, Wagner SC. Venlafaxine in the treatment of borderline personality disorder. Psychopharmacol Bull 1995;31:773-7.